Novartis (Sweden)-ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2022

  1. Transient Inhibition of the JAK/STAT Pathway Prevents B-ALL Development in Genetically Predisposed Mice

    Cancer research, Vol. 82, Núm. 6, pp. 1098-1109